Company

ELI LILLY & Co (LLY)

Standardized SEC financial data for ELI LILLY & Co — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0000059478 · NYSE · Pharmaceutical Preparations.

Gross margin

83.0%

Net margin

31.7%

Revenue growth (YoY)

44.7%

Return on equity

77.8%

Free cash flow

$16.81B

Debt / equity

1.54×

Current ratio

1.58×

EPS (diluted)

$22.95

Ratios for fiscal year 2025, standardized from SEC filings.

Income statement

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$24.54B	$28.32B	$28.54B	$34.12B	$45.04B	$65.18B
Cost of revenue	$5.48B	$7.31B	$6.63B	$7.08B	$8.42B	$11.05B
Gross profit	$19.06B	$21.01B	$21.91B	$27.04B

Balance sheet

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$3.66B	$3.82B	$2.07B	$2.82B	$3.27B	$7.27B
Inventory	$3.98B	$3.89B	$4.31B	$5.77B	$7.59B	$13.74B
Total current assets	$17.46B	$18.45B	$18.03B	$25.73B

Cash flow

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	$6.50B	$7.37B	$7.59B	$4.24B	$8.82B	$16.81B
Investing cash flow	-$2.26B	-$2.87B	-$3.76B	-$7.15B	-$9.30B	-$10.97B
Financing cash flow	-$3.14B	-$4.13B	-$5.41B	$3.50B

Get LLY data via API

# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/LLY/financials \
  -H "X-API-Key: YOUR_KEY"

# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/LLY/income-statement?format=csv" \
  -H "X-API-Key: YOUR_KEY"

Get a free API key Use with Claude (MCP) →View LLY filings on SEC EDGAR →